Global Vascular Access Devices Market Size By Type (CVC Catheters, Implantable Port), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment Forecasts, 2023 to 2032

The Global Vascular Access Devices Market was valued at USD 5.9 billion in 2023 and is projected to surpass USD 9.7 billion by 2031, growing at a CAGR of 6.6% during the forecast period from 2023 to 2031. The increasing incidence of chronic diseases, rising number of hospital admissions, and the growing demand for minimally invasive procedures are major factors driving the market. These devices are critical in administering medications, fluids, and nutrition, especially for patients undergoing chemotherapy, dialysis, or long-term intravenous therapies. The integration of advanced materials and technologies for improved biocompatibility and infection control is further enhancing product adoption globally.

Drivers:

1. Rising Incidence of Chronic Diseases:

Chronic conditions like cancer, kidney failure, and diabetes are contributing to higher hospitalizations and long-term treatments that require frequent vascular access. This drives demand for reliable vascular access devices.

2. Advancements in Device Technology:

New-generation vascular access devices now include antimicrobial coatings, pressure sensors, and catheter stabilization features that reduce infection risks and improve patient outcomes.

3. Growing Surgical Procedures and Hospital Admissions:

The rise in surgical procedures, especially among the aging population, necessitates the use of vascular access devices for fluid management, anesthesia delivery, and postoperative care.

Restraints:

1. Risk of Catheter-Related Infections and Complications:

Infection, thrombosis, and device malfunctions remain significant concerns, deterring some healthcare providers from broader use without appropriate controls.

2. High Cost of Advanced Devices:

While innovation drives better outcomes, the cost of sophisticated vascular access devices can be a limiting factor, particularly in low-resource healthcare settings.

Opportunity:

1. Expansion in Emerging Economies:

Developing nations are witnessing rapid improvements in healthcare infrastructure, with increased spending on hospital care and infusion therapies, offering untapped potential for market players.

2. Adoption of Home-Based Healthcare and Long-Term Care:

The trend toward home healthcare and ambulatory infusion therapies supports the adoption of portable and easy-to-use vascular access devices, particularly for aging and chronically ill populations.

Market by System Type Insights:

By system type, the Peripherally Inserted Central Catheters (PICC) segment held the largest share in 2023. PICCs offer advantages such as longer dwell times and lower infection rates compared to traditional central lines. The Implantable Ports segment is expected to witness the fastest growth due to its increasing use in oncology and long-term intravenous treatments, offering both patient convenience and clinical efficacy.

Market by End-use Insights:

In terms of end-use, Hospitals dominated the market in 2023, accounting for over 45% of global revenue. Hospitals require high volumes of vascular access devices for surgery, intensive care, and treatment of chronic illnesses. Meanwhile, the Home Healthcare segment is anticipated to register strong growth due to the rising preference for outpatient care and infusion therapy outside hospital settings.

Market by Regional Insights:

North America led the market in 2023, owing to a high prevalence of chronic diseases, well-established healthcare systems, and widespread adoption of technologically advanced products. Asia-Pacific, however, is poised to grow at the fastest rate during the forecast period, driven by healthcare infrastructure development, expanding geriatric population, and increasing health awareness in countries like China and India.

Competitive Scenario:

Leading companies in the Global Vascular Access Devices Market include Becton, Dickinson and Company, Teleflex Incorporated, B. Braun Melsungen AG, AngioDynamics, Smiths Medical, ICU Medical, Inc., Terumo Corporation, Nipro Corporation, Vygon Group, and Medtronic plc. Strategic collaborations, innovation in catheter technology, and geographical expansion are the key strategies adopted. For instance:

2023: BD launched a new line of antimicrobial central venous catheters to reduce bloodstream infections.

2024: Teleflex partnered with a major U.S. hospital group to pilot AI-integrated vascular access monitoring systems.

2025: Terumo introduced a next-gen implantable port system with enhanced patient comfort and insertion accuracy.

Scope of Work – Global Vascular Access Devices Market

Report Metric Details

Market Size (2023) USD 5.9 Billion

Projected Market Size (2031) USD 9.7 Billion

CAGR (2023-2031) 6.6%

Market Segments By System Type, End-Use, Region

Growth Drivers Chronic disease prevalence, device advancements

Opportunities Home healthcare growth, emerging market expansion

Key Market Developments:

July 2023: Smiths Medical unveiled a hybrid vascular access system with dual modality imaging capabilities for precision placement.

March 2024: AngioDynamics acquired a vascular technology firm to integrate smart sensor-enabled ports.

January 2025: ICU Medical partnered with telehealth platforms to optimize vascular access tracking and remote patient monitoring.

FAQs:

1) What is the current market size of the Global Vascular Access Devices Market?

The market was valued at USD 5.9 billion in 2023.

2) What is the major growth driver of the Global Vascular Access Devices Market?

The major driver is the rising incidence of chronic diseases requiring long-term intravenous treatments.

3) Which is the largest region during the forecast period in the Global Vascular Access Devices Market?

North America is the largest region due to high adoption of advanced vascular a